Laman UtamaEYPT • NASDAQ
add
EyePoint Inc
Tutup sebelumnya
$14.92
Julat hari
$13.51 - $14.90
Julat tahun
$3.91 - $19.01
Permodalan pasaran
1.17B USD
Bilangan Purata
1.73J
Nisbah P/E
-
Hasil dividen
-
Pertukaran utama
NASDAQ
Kewangan
Penyata Pendapatan
Hasil
Pendapatan bersih
| (USD) | Dis 2025info | Perubahan T/T |
|---|---|---|
Hasil | 620.00K | -94.65% |
Perbelanjaan pengendalian | 12.39J | -8.95% |
Pendapatan bersih | -67.61J | -63.31% |
Margin untung bersih | -10.90K | -2,952.31% |
Pendapatan bagi setiap syer | -0.81 | -26.56% |
EBITDA | -69.65J | -55.56% |
Kadar cukai berkesan | -0.28% | — |
Kunci Kira-kira
Jumlah aset
Jumlah liabiliti
| (USD) | Dis 2025info | Perubahan T/T |
|---|---|---|
Pelaburan tunai dan jangka pendek | 306.09J | -17.48% |
Jumlah aset | 364.00J | -13.02% |
Jumlah liabiliti | 57.88J | -29.38% |
Jumlah ekuiti | 306.11J | — |
Syer tertunggak | 83.43J | — |
Harga kepada buku | 4.03 | — |
Pulangan pada aset | -57.13% | — |
Pulangan pada modal | -63.68% | — |
Aliran Tunai
Perubahan bersih dalam tunai
| (USD) | Dis 2025info | Perubahan T/T |
|---|---|---|
Pendapatan bersih | -67.61J | -63.31% |
Tunai daripada operasi | -65.05J | -81.45% |
Tunai daripada pelaburan | -74.67J | 22.19% |
Tunai daripada pembiayaan | 166.96J | 10.07% |
Perubahan bersih dalam tunai | 27.24J | 37.08% |
Aliran tunai bebas | -41.14J | -131.88% |
Perihal
EyePoint Pharmaceuticals Inc. is a Watertown, Massachusetts company specialising in the application of microelectromechanical systems and nanotechnology to drug delivery.
pSivida obtained porous silicon technology from the British government Defence Evaluation and Research Agency. QinetiQ continues to be a strategic partner.
In June 2004, pSivida acquired full ownership of pSiMedica. In April 2018, pSivida purchased eye products firm Icon Bioscience. Afterwards, it rebranded to its current name of EyepOint Pharmaceuticals, Inc. Wikipedia
Diasaskan
2000
Ibu pejabat
Tapak web
Pekerja
214
